@Data
FĂR DAS TUBERKULOSE PROBLEM DURCH DIE INJECTIONS -đ¤
đ
Centre of Excellence for Long-acting Therapeutics
CELTLiverpool
SDN tech is an #innovation developed by CELT scientists and is fundamental to the
đ đ #LONGEVITYProject.
Using this #nanotechnology we are developing vital new #longacting medicines for #LMICs
#nanoparticles #malaria #TB #HCV
Learn about our strategy đ
https://nitter.kavin.rocks/CELTLiverpool/status/1632737899195035651#m
#innovation #longevityproject #nanotechnology #longacting #lmics #nanoparticles #malaria #tb #hcv